EAA (Essential Amino Acids).

Leucine is the amino acid that signals mTORC1 to start muscle protein synthesis, and the remaining essential amino acids supply the building blocks that signal then draws on. Leucine alone raises the signal without the substrate, so the two belong together.

HMB is formed from a small fraction of dietary leucine and acts mainly on protein breakdown, while the essential amino acid pool feeds synthesis. The two sit on opposite sides of the same turnover balance.

Creatine recharges phosphocreatine for short bursts of force, while essential amino acids supply the nitrogen for the tissue built afterwards. Neither substitutes for the other, which is why they are routinely formulated side by side.

Pyridoxal-5-phosphate is the cofactor for the transaminases and decarboxylases that move nitrogen between amino acids. A larger amino acid load raises the demand on that cofactor pool.

Whey already delivers all nine essential amino acids in an intact, rapidly digested form, so added free-form EAAs stack onto the same pool rather than adding a new one. The practical difference is speed of appearance in blood, not composition.

Tryptophan and the branched-chain amino acids in an EAA blend cross the blood brain barrier on the same large neutral amino acid carrier. A large EAA dose lowers the share of that carrier available to tryptophan, so taking them at the same time works against tryptophan's central purpose.

Tyrosine uses the same large neutral amino acid carrier as the branched-chain amino acids for brain entry. Co-dosing with a full EAA blend dilutes tyrosine's access to that carrier, so separating them by a couple of hours preserves the intended effect.

Lysine, a required member of any essential amino acid blend, shares the CAT-1 transporter with arginine at the gut wall and the cell membrane. High lysine intake lowers arginine uptake through that shared route.

Isoleucine shares its transporter and its first two catabolic enzymes with leucine, so a leucine-heavy blend lowers circulating isoleucine. Keeping the branched-chain ratio balanced within the EAA profile avoids that drawdown.

Valine is one of the three branched-chain essential amino acids and shares the BCAT transaminase and branched-chain ketoacid dehydrogenase complex with leucine and isoleucine. A balanced EAA blend includes it by definition, and leaving it out while dosing leucine heavily skews the catabolic pathway toward one substrate. Its inclusion is a composition requirement rather than an added effect.

Lysine is essential, is the limiting amino acid in cereal proteins, and is the carbon skeleton from which carnitine is synthesised. A blend built for muscle protein synthesis needs it present in proportion or the pattern limits at lysine. It also has a distinct role in collagen cross-linking after hydroxylation.

Methionine is essential and is the entry point of the one-carbon cycle, being adenosylated to S-adenosylmethionine, the universal methyl donor. Its presence in an EAA blend therefore does two jobs, supplying the residue for protein synthesis and feeding methylation. Downstream it produces homocysteine, which is remethylated or moved through transsulphuration.

Histidine is essential in humans and is the rate-limiting substrate for carnosine synthesis in skeletal muscle, the same dipeptide beta-alanine supplementation targets from the other side. It is also the precursor of histamine. A blend that omits it is not a complete essential pattern.

Phenylalanine is essential and is hydroxylated to tyrosine, which then feeds the catecholamine pathway through DOPA. Because tyrosine can be made from phenylalanine but not the other way round, phenylalanine is the one of the pair that must come from the diet. Its labelled form is also the standard tracer in muscle protein synthesis measurement.

Threonine is essential and is used heavily by the gut for mucin synthesis before any reaches systemic circulation. Splanchnic extraction is therefore high, which is one reason a complete blend supplies more of it than the systemic requirement alone would suggest. It is a composition requirement of a complete pattern.

Biotin is the covalently bound cofactor of methylcrotonyl-CoA carboxylase and propionyl-CoA carboxylase, two of the carboxylases that carry leucine, isoleucine and valine catabolism forward. Without adequate biotin those steps stall and their upstream metabolites accumulate. This is settled cofactor biochemistry, not a combination finding.

FAD, derived from riboflavin, is the prosthetic group of the acyl-CoA dehydrogenases that act on the branched-chain ketoacid skeletons, and it also serves the branched-chain ketoacid dehydrogenase complex. Riboflavin status therefore sits underneath branched-chain amino acid disposal. Supplying the substrate without the flavin cofactor constrains the pathway.

Adenosylcobalamin is the cofactor of methylmalonyl-CoA mutase, the step that carries the propionyl-CoA produced from isoleucine, valine, methionine and threonine catabolism into the citric acid cycle. Methylcobalamin serves methionine synthase on the other side of the cycle. Both roles put B12 directly in the disposal route for essential amino acid carbon.

5-methyltetrahydrofolate is the methyl donor that methionine synthase uses to remethylate homocysteine back to methionine. A large methionine load raises flux through that cycle. Folate status therefore determines how readily the homocysteine generated downstream is recycled.

Betaine-homocysteine methyltransferase remethylates homocysteine using trimethylglycine as the methyl donor, a folate-independent parallel route to the methionine synthase reaction. It is most active in liver and kidney. This gives a second outlet for the homocysteine generated by methionine turnover.

Ascorbate keeps the iron centre of prolyl and lysyl hydroxylases in the reduced state, and those enzymes hydroxylate proline and lysine residues during collagen assembly. Lysine also needs two ascorbate-dependent hydroxylation steps on its way to carnitine. Both are places where an essential amino acid cannot proceed without the vitamin.

Peptide bond formation on the ribosome runs on GTP and ATP hydrolysis, and every one of those nucleotides acts as a magnesium complex. Magnesium also stabilises ribosomal structure itself. Supplying amino acids does not address the cofactor side of the same reaction.

The vitamin D receptor is expressed in skeletal muscle and has been described as influencing how muscle responds to an amino acid stimulus. The human work pairs vitamin D status with muscle measures rather than testing it against an EAA dose directly. Muscle protein synthesis rate is a marker measured over hours, not a clinical outcome.

EPA and DHA incorporate into the muscle phospholipid membrane, and this has been described as altering the sensitivity of muscle protein synthesis to a given amino acid dose. The endpoint in that work is a synthesis rate measured with a tracer, which is a marker. The two are usually dosed on different schedules, since the membrane change takes weeks.

5-HTP and the large neutral amino acids phenylalanine, leucine, isoleucine, valine, methionine and tryptophan all cross the blood-brain barrier on the LAT1 carrier, and they compete for it. A full EAA dose therefore raises the competing pool and lowers the fraction of a 5-HTP dose that reaches the brain. Separating the two by a couple of hours is the standard way around it.

Casein clots in the stomach and releases amino acids slowly, while free-form EAAs appear in plasma within about half an hour. Combining them gives a fast peak on top of a slower release rather than duplicating one profile. The comparison is about absorption kinetics, not about which protein is better.

Collagen carries no tryptophan and very little of the branched-chain residues, so it is not a complete protein by itself and cannot drive muscle protein synthesis the way a complete pattern does. An EAA blend supplies exactly the residues collagen lacks. Where collagen is being taken for connective tissue, the EAAs cover the pattern gap rather than replacing it.

Zinc is a structural component of hundreds of enzymes and transcription factors involved in protein turnover, and zinc status is a known determinant of growth. The link to a specific EAA dose is indirect. It is listed as a cofactor context rather than as a tested pairing.

Citrulline raises plasma arginine and, through nitric oxide, muscle perfusion, which is one of the variables governing how quickly an amino acid dose is delivered to the tissue. The two are frequently combined in intra-workout formulas for that reason. No trial has tested whether the perfusion change alters the amino acid response.